Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Therapeutic Potential of Stem Cells for Treatment of Neurodegenerative Diseases Publisher Pubmed



Ahmadianmoghadam H1 ; Sadatshirazi MS1 ; Zarrindast MR1, 2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Genetic, Iranian National Center for Addiction Studies, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Pharmacology, School of Medicine, Tehran University of Medical Sciences, P.O. Box 13145-784, Tehran, Iran

Source: Biotechnology Letters Published:2020


Abstract

Neurodegenerative diseases are caused by a loss of neurons within the peripheral or central nervous system. Inadequate repairability in the central nervous system and failure of treatments are the significant hurdles for several neurological diseases. The regenerative potential of stem cells drew the attention of researchers to cell-based therapy for treating neurodegenerative diseases. The clinical application of stem cells may help to substitute new cells and overcome the inability of the endogenous repairing system to repair the damaged brain. However, the clinical application induced pluripotent stem cells are restricted due to the risk of tumor formation by residual undifferentiated upon transplantation. In this focused review, we briefly discussed different stem cells currently being studied for therapeutic development. Moreover, we present supporting evidence for the utilization of stem cell therapy for the treatment of neurodegenerative diseases. Also, we described the key issues that should be considered to transplantation of stem cells for different neurodegenerative diseases. In our conclusion, stem cell therapy probably would be the only treatment strategy that offers a cure for neurodegenerative disease. Although, further study is required to identify ideal stem cells candidate, dosing and the ideal method of cell transplantation. We suggest that all grafted cells would be transgenically armed with a molecular kill-switch that could be activated by the event of adverse side effects. © 2020, Springer Nature B.V.
Related Docs
View other Related Docs
1. Stem Cell in Neurodegenerative Disorders; an Emerging Strategy, International Journal of Developmental Neuroscience (2021)
2. Autologous Hematopoietic Stem-Cell Transplantation in Multiple Sclerosis: A Systematic Review and Meta-Analysis, Neurology and Therapy (2022)
3. Clinical Cell Therapy Guidelines for Neurorestoration (Ianr/Canr 2017), Cell Transplantation (2018)
4. Neural Stem/Progenitor Cell Transplantation for Spinal Cord Injury Treatment; a Systematic Review and Meta-Analysis, Neuroscience (2016)
5. Stem Cell- and Gene-Based Therapies As Potential Candidates in Alzheimer's Therapy, Journal of Cellular Biochemistry (2018)
6. Mesenchymal Stromal Cells (Mscs) for Neurodegenerative Disease: A Promising Frontier, European Journal of Cell Biology (2020)
7. Neuroprotective Effects of Bone Marrow Mesenchymal Stem Cells on Bilateral Common Carotid Arteries Occlusion Model of Cerebral Ischemia in Rat, Behavioural Neurology (2016)
8. Emerging Stem Cell Therapy and Tissue Engineering-Based Approaches in Neurodegenerative Diseases, Handbook of Stem Cell Applications (2024)
Experts (# of related papers)
View all Related Experts
Somayeh Ebrahimi Barough (7)
Iraj Ragerdi Kashani (6)
Other Related Docs
9. Stem Cell-Based Approach for the Treatment of Parkinson's Disease, Medical Journal of the Islamic Republic of Iran (2015)
10. Emerging Role of Mesenchymal Stromal Cells (Mscs)-Derived Exosome in Neurodegeneration-Associated Conditions: A Groundbreaking Cell-Free Approach, Stem Cell Research and Therapy (2022)
11. Direct Mechanical Thrombectomy Versus Prior Bridging Intravenous Thrombolysis in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis, Life (2023)
12. Mesenchymal Stem Cells in the Treatment of Amyotrophic Lateral Sclerosis, Current Stem Cell Research and Therapy (2016)
13. The Safety and Efficacy of Neva Mechanical Thrombectomy Device in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis, Journal of Clinical Neuroscience (2024)
14. Dysfunction in Brain-Derived Neurotrophic Factor Signaling Pathway and Susceptibility to Schizophrenia, Parkinson’S and Alzheimer’S Diseases, Current Gene Therapy (2018)
15. Bone Marrow-Derived Mesenchymal Stem Cell and Simvastatin Treatment Leads to Improved Functional Recovery and Modified C-Fos Expression Levels in the Brain Following Ischemic Stroke, Iranian Journal of Basic Medical Sciences (2018)
16. Efficacy and Safety of Mechanical Thrombectomy in Patients With Acute Ischemic Stroke and Left Ventricular Assist Device: Review of the Literature and Meta-Analysis, Journal of NeuroInterventional Surgery (2025)
17. Mechanisms and Potentials of Stem Cells in the Treatment of Multiple Sclerosis: The Unpaved Path, Multiple Sclerosis: A Mechanistic View (2016)
18. Cell-Based Therapy for Spinal Muscular Atrophy, Advances in Experimental Medicine and Biology (2020)
19. Transplantation of Fetal Stem Cells: A New Horizon for Treatment of Degenerative Diseases, Iranian Journal of Public Health (2015)
20. Advanced Approaches to Regenerate Spinal Cord Injury: The Development of Cell and Tissue Engineering Therapy and Combinational Treatments, Biomedicine and Pharmacotherapy (2022)
21. Application of Mesenchymal Stem Cells (Mscs) in Neurodegenerative Disorders: History, Findings, and Prospective Challenges, Pathology Research and Practice (2023)
22. Induced Pluripotent Stem Cells (Ipscs) As Game-Changing Tools in the Treatment of Neurodegenerative Disease: Mirage or Reality?, Journal of Cellular Physiology (2020)
23. The Protective Effects of Neural Stem Cells and Neural Stem Cells-Conditioned Medium Against Inflammation-Induced Prenatal Brain Injury, Journal of Neuroimmunology (2021)
24. Microrna Machinery in Parkinson’S Disease: A Platform for Neurodegenerative Diseases, Expert Review of Neurotherapeutics (2022)
25. A Hybrid Microfluidic System for Regulation of Neural Differentiation in Induced Pluripotent Stem Cells, Journal of Biomedical Materials Research - Part A (2016)
26. Safety, Feasibility of Intravenous and Intrathecal Injection of Autologous Bone Marrow Derived Mesenchymal Stromal Cells in Patients With Amyotrophic Lateral Sclerosis: An Open Label Phase I Clinical Trial, Cell Journal (2019)
27. Alterations in Apoptotic Pathways and Expression of Mir-134, Mir-181, and Mir-497 Induced by Wharton's Jelly-Derived Mesenchymal Stem Cells in a Rat Model of Ischemic Brain Injury, IBRO Neuroscience Reports (2025)
28. Development and Validation of Alzheimer’S Disease Animal Model for the Purpose of Regenerative Medicine, Cell and Tissue Banking (2019)
29. Pcl/Gelatin Scaffolds and Beta-Boswellic Acid Synergistically Increase the Efficiency of Cgr8 Stem Cells Differentiation Into Dopaminergic Neuron: A New Paradigm of Parkinson's Disease Cell Therapy, Journal of Biomedical Materials Research - Part A (2021)
30. Outcome of Treatment With Intravenous Alteplase in Acute Stroke Patients, Journal of Babol University of Medical Sciences (2023)
31. Role of P38/Mapks in Alzheimer's Disease: Implications for Amyloid Beta Toxicity Targeted Therapy, Reviews in the Neurosciences (2019)
32. The Exo-Microrna (Mirna) Signaling Pathways in Pathogenesis and Treatment of Stroke Diseases: Emphasize on Mesenchymal Stem Cells (Mscs), Cell Biochemistry and Function (2024)
33. The Effect of Microglial Ablation and Mesenchymal Stem Cell Transplantation on a Cuprizone-Induced Demyelination Model, Journal of Cellular Physiology (2021)
34. Chitosan-Intercalated Montmorillonite/Poly(Vinyl Alcohol) Nanofibers As a Platform to Guide Neuronlike Differentiation of Human Dental Pulp Stem Cells, ACS Applied Materials and Interfaces (2017)
35. Astrocyte Ablation Induced by La-Aminoadipate (L-Aaa) Potentiates Remyelination in a Cuprizone Demyelinating Mouse Model, Metabolic Brain Disease (2019)
36. A Controlled, Randomized Phase Ii Clinical Trial for Efficacy and Safety Evaluation of Mannuronic Acid in Secondary Progressive Form of Multiple Sclerosis, International Journal of Neuroscience (2022)
37. Clinical Cell Therapy Guidelines for Neurorestoration (Ianr/Canr 2022), Journal of Neurorestoratology (2022)
38. Effect of Csf1r Inhibitor on Glial Cells Population and Remyelination in the Cuprizone Model, Neuropeptides (2021)
39. Pesticides and Parkinson's Disease: Current and Future Perspective, Journal of Chemical Neuroanatomy (2021)
40. Human Bone Marrow-Derived and Umbilical Cord-Derived Mesenchymal Stem Cells for Alleviating Neuropathic Pain in a Spinal Cord Injury Model, Stem Cell Research and Therapy (2016)
41. Multiple Sclerosis Pathogenesis: Missing Pieces of an Old Puzzle, Reviews in the Neurosciences (2019)
42. Tissue Engineering Scaffolds in the Treatment of Brain Disorders in Geriatric Patients, Artificial Organs (2019)
43. Intranasal Delivery of Sdf-1Α-Preconditioned Bone Marrow Mesenchymal Cells Improves Remyelination in the Cuprizone-Induced Mouse Model of Multiple Sclerosis, Cell Biology International (2020)
44. Stem Cell Tracing Through Mr Molecular Imaging, Tissue Engineering and Regenerative Medicine (2018)
45. Mesenchymal Stem Cells Ameliorate Cuprizone-Induced Demyelination by Targeting Oxidative Stress and Mitochondrial Dysfunction, Cellular and Molecular Neurobiology (2021)
46. Mesenchymal Stromal Cell-Derived Secretome-Based Therapy for Neurodegenerative Diseases: Overview of Clinical Trials, Stem Cell Research and Therapy (2023)
47. Anterior Ischemic Stroke: Analysis of the Multivariable Ct-Based Models for Prediction of Clinical Outcome, Journal of Stroke and Cerebrovascular Diseases (2023)
48. Tissue Engineered Skin Substitutes, Advances in Experimental Medicine and Biology (2018)
49. Anxiolytic Impact of Apelin-13 in a Rat Model of Alzheimer's Disease: Involvement of Glucocorticoid Receptor and Fkbp5, Peptides (2019)
50. The Extracellular Vesicles-Derived From Mesenchymal Stromal Cells: A New Therapeutic Option in Regenerative Medicine, Journal of Cellular Biochemistry (2018)